SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001185185-12-001341
Filing Date
2012-06-14
Accepted
2012-06-14 14:46:37
Documents
11
Period of Report
2012-04-30
Filing Date Changed
2012-06-14

Document Format Files

Seq Description Document Type Size
1 lightlake10q043012.htm 10-Q 762579
2 ex31-1.htm EX-31.1 12704
3 ex31-2.htm EX-31.2 12630
4 ex32-1.htm EX-32.1 7186
5 ex32-2.htm EX-32.2 6687
  Complete submission text file 0001185185-12-001341.txt   2388296

Data Files

Seq Description Document Type Size
6 lltp-20120430.xml EX-101.INS 258305
7 lltp-20120430.xsd EX-101.SCH 17423
8 lltp-20120430_cal.xml EX-101.CAL 18723
9 lltp-20120430_def.xml EX-101.DEF 91261
10 lltp-20120430_lab.xml EX-101.LAB 108500
11 lltp-20120430_pre.xml EX-101.PRE 92471
Mailing Address 54 BAKER STREET 6TH FLOOR LONDON X0 W1U 7BU
Business Address 54 BAKER STREET 6TH FLOOR LONDON X0 W1U 7BU 44-207-034-1943
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 12907333
SIC: 1000 Metal Mining
Assistant Director 9